In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced a major, peer-reviewed publication demonstrating the power of ...

Nipah virus fatality rates are 40% to 75%. It's typically spread between humans and bats through people consuming ...

UPSC Prelims 2026 preparation guide for Science & Technology section. Check smart strategy, important topics, best sources, ...

Americans love science and revere innovation, almost as a rule, and politicians of every stripe have spent the better part of a century promoting and protecting both. However imperfect the resulting ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with ...

It already exists in the natural world. Now, thanks to breakthroughs in genetic engineering, scientists have created ...

Novo takes aim at Hims & Hers over compounded version of Wegovy pill; The flaw with TrumpRx; Vertex Pharmaceuticals’ CRISPR treatment for sickle cell disease hit an unexpected roadblock.

Among an upended global health order, medical innovation pushes forward. Read how TIME chose the list of doctors, scientists and more.